EANM guideline on quality risk management for radiopharmaceuticals.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 35385986.
- Also identified by DOI 10.1007/s00259-022-05738-4 and PMC identifier 9308578.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
Medical subject headings
- Nuclear Medicine
- Radiopharmaceuticals